ZURA – zura bio limited - class a ordinary shares (US:NASDAQ)
Stock Stats
News
Zura Bio to Present at the Leerink Partners Global Healthcare Conference
Zura Bio Limited (NASDAQ: ZURA) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
Zura Bio Launches Global Phase 2 TibuSURE Study to Evaluate Tibulizumab in Adults With Systemic Sclerosis
Form 4 Zura Bio Ltd For: Feb 27 Filed by: Whale Gary
Form 4 Zura Bio Ltd For: Feb 27 Filed by: Nistala Kiran
Form 4 Zura Bio Ltd For: Feb 27 Filed by: Lisicki Robert
Form 4 Zura Bio Ltd For: Feb 27 Filed by: Davis Kim
Form 8-K Zura Bio Ltd For: Feb 24
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.